Status:
RECRUITING
Effects of Dry Needling on Electromyographic Activity and Ultrasonographic Characteristics in Post-Stroke Spasticity
Lead Sponsor:
Universidad de Zaragoza
Collaborating Sponsors:
University of Alcala
Conditions:
Spasticity as Sequela of Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Stroke is a global health problem, with an incidence in Europe of 147/100,000 people per year. It is estimated that 43% of them present spasticity throughout the first year, causing disability, hinder...
Detailed Description
The aim of the study is to analyse the effect of dry needling in stroke patients. The investigators hypothesized dry needling will decrease spasticity and electromyographic activity of spastic muscles...
Eligibility Criteria
Inclusion
- be over 18 years old
- understand and voluntarily sign informed consent before performing the intervention
- have a medical diagnosis of ischemic or hemorrhagic stroke
- have a grade between 1-3 according to the modified Ashworth scale (MAS) on the triceps sural
- able to walk independently to perform gait test
Exclusion
- recurrent stroke
- who have received previous treatments of botulinum toxin type A in the last 3 months
- who have received treatments with dry needling in the last month
- severe cognitive deficits
- fear of needles
- metal allergy.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 15 2026
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06017960
Start Date
September 15 2023
End Date
September 15 2026
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Europeo de Neurociencias
Madrid, Madrid, Spain, 28023